Antithrombin IIi during liver transplantation
Lewis, J.H.; Bontempo, F.A.; Ragni, M.V.; Starzl, T.E.
Transplantation Proceedings 21(3): 3543-3544
1989
ISSN/ISBN: 0041-1345 PMID: 2662520 Document Number: 340769
Document emailed within 1 workday
Related Documents
Haussmann, U.; Fischer, J.; Eber, S.; Scherer, F.; Seger, R.; Gungor, T. 2006: Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy Haematologica 91(6): 795-800Denecke, C.; Weiss, S.; Biebl, M.; Fritz, J.; Dziodzio, T.; Aigner, F.; Sucher, R.; Brandl, A.; Bösmüller, C.; Pratschke, J.; Öllinger, R. 2016: An Arterial Conduit is Not a Risk Factor for Survival Following Orthotopic Liver Transplantation: An Analysis of 20 Years of Liver Transplantation in Innsbruck Annals of transplantation 21: 321-328
Ishine, N.; Tanaka, N.; Yagi, T.; Oishi, M.; Ishikawa, T.; Orita, K. 1996: Postreperfusion syndrome in swine liver transplantation: comparison between orthotopic liver transplantation and total hepatectomy with portacaval shunt using aortic graft Transplantation Proceedings 28(3): 1756-1758
Rodríguez Cuartero, A.; Mora Guijosa, A.; Núñez Carril, J. 1991: Antithrombin IIi and liver cirrhosis Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 79(1): 21-23
Lerut, J.; Stieber, A.C.; Makowka, L.; Esquivel, C.O.; Iwatsuki, S.; Gordon, R.D.; Starzl, T.E. 1989: Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center Helvetica Chirurgica Acta 56(3): 405-420
Mannucci, L.; Dioguardi, N.; Del Ninno, E.; Mannucci, P.M. 1973: Value of Normotest and antithrombin 3 in the assessment of liver function Scandinavian Journal of Gastroenterology. Suppl 19: 103-107
Rambusch, E.G.; Nashan, B.; Tillmann, H.L.; Böker, K.H.; Schlitt, H.J.; Maschek, H.; Raab, R.; Manns, M.P. 1998: De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates Zeitschrift für Gastroenterologie 36(12): 1027-1035
Jeong, H.; Kim, M.; Lee, J.; Hahn, S.H.; Park, S.; Yoo, O.J. 1997: A 5-nucleotide insertion in the antithrombin gene causing a quantitative antithrombin deficiency Thrombosis and Haemostasis 77(1): 212-213
Gerhards, H. 1987: Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency Tierarztliche Praxis 15(1): 47-55
Fujimaki, M.; Nagasawa, H. 1974: Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3 Nihon Rinsho. Japanese Journal of Clinical Medicine 32(5): 942-947
Boneu, B.; Sie, P.; Caranobe, C.; Cassigneul, J.; Pascal, J. 1982: Progressive antithrombin activity and the concentration of three thrombin inhibitors in liver cirrhosis Thrombosis and Haemostasis 47(1): 78
Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J. 2002: Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122
Cienfuegos Suarez, J.A.; Pardo Sánchez, F.; Maganto Suárez, P. 1989: Liver transplantation. new perspectives in pediatric liver transplantation Anales Espanoles de Pediatria 31(Suppl 39): 93-98
Shinyama, H.; Akira, T.; Uchida, T.; Hirahara, K.; Watanabe, M.; Kagitani, Y. 1996: Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia Journal of Cardiovascular Pharmacology 27(5): 702-711
Patton, D.F.; Harper, J.L.; Wooldridge, T.N.; Gordon, B.G.; Coccia, P.; Haire, W.D. 1996: Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate Bone Marrow Transplantation 17(3): 443-447
Steinig, D.; Mentha, G.; Lecoultre, C.; Pittet, J.F.; Jeanjacquot, A.; Huber, O.; Meyer, P.; Rohner, A. 1990: Experimental porcine orthotopic liver transplantation: a training protocol for transplantation in humans Helvetica Chirurgica Acta 57(1): 177-186
Terajima, H.; Tanaka, K.; Okajima, K.; Inomata, Y.; Yamaoka, Y. 1995: Timing of transplantation and donor selection in living related liver transplantation for fulminant Wilson's disease Transplantation Proceedings 27(1): 1177-1178
Di Cosmo, S.; Lusignani, M.; Manini, M.; Accardi, R. 2018: Prevalence and risk factors of overweight and obesity after liver transplantation: retrospective study at three years after transplantation Professioni Infermieristiche 71(1): 3-10
Kumanov, C.; Deyanov, G.; Brunkov, D.; Gicheva, M. 2009: Liver transplantation in Bulgaria and mission of the Executive Agency of Transplantation Khirurgiia 2009(2-3): 66-68
Yamaguchi, A.; Yamadera, H.; Matsuda, M.; Sumimoto, R.; Kamada, N. 1991: Cellular basis of transplantation tolerance induced by rat liver transplantation: evidence for suppressor cell activity in vivo Transplantation Proceedings 23(1 Part 1): 866-867